Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Colorcon
AstraZeneca
McKinsey
Dow

Last Updated: November 16, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,787,529

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 6,787,529 protect, and when does it expire?

Patent 6,787,529 protects TACLONEX and is included in one NDA.

This patent has thirty-two patent family members in twenty-two countries.

Summary for Patent: 6,787,529
Title: Topical composition
Abstract:The present invention relates to a pharmaceutical gel composition for application on skin, said composition comprising at least one vitamin D or vitamin D analogue and at least one corticosteroid as well as a viscosity-increasing excipient.
Inventor(s): H.o slashed.y; Gert (Jyllinge, DK), Didriksen; Erik Johannes (Ballerup, DK)
Assignee: Leo Pharmaceutical Products Ltd. A/S (Ballerup, DK)
Application Number:09/984,072
Patent Claim Types:
see list of patent claims
Composition; Compound; Use;

Drugs Protected by US Patent 6,787,529

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene SUSPENSION;TOPICAL 022185-001 May 9, 2008 RX Yes Yes   Start Trial   Start Trial Y PLAQUE PSORIASIS   Start Trial
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene SUSPENSION;TOPICAL 022185-001 May 9, 2008 RX Yes Yes   Start Trial   Start Trial Y TREATMENT OF MODERATE PLAQUE PSORIASIS   Start Trial
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene SUSPENSION;TOPICAL 022185-001 May 9, 2008 RX Yes Yes   Start Trial   Start Trial Y PSORIASIS   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,787,529

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 380542   Start Trial
Australia 2001291637   Start Trial
Australia 9163701   Start Trial
Brazil 0114927   Start Trial
Canada 2423930   Start Trial
China 100382803   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Mallinckrodt
Moodys
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.